6 hrs ago | Bioscience Technology
Researchers that use the pre-genomic tools, such as the microarray, to study modern biological problems in stem cells think so.
14 hrs ago | Medical News Today
$11 Million NIH Grant For Stem Cell Research Awarded To Rhode Island Hospital
Main Category: Stem Cell Research Also Included In: Respiratory / Asthma ; Bones / Orthopaedics Article Date: 07 Nov 2009 - 1:00 PST Rhode Island Hospital has received an $11 million grant to fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration in lung and marrow ...
22 hrs ago | RedOrbit
Gene Therapy Success In Severe Brain Disorder Applauded By The Stop Ald Foundation
The Stop ALD Foundation today applauded the investigators who are reporting in the current issue of Science successful results from the pioneering use of gene therapy for adrenoleukodystrophy , a potentially crippling and fatal brain disorder in young boys.
State Agency Grants Signal Shift Away from Embryonic Stem Cells
In an April cover story , we looked at the dilemma facing the California Institute for Regenerative Medicine , the state agency created through Proposition 71 to fund stem-cell research: Should the landmark agency direct the remainder of its $3 billion in research funds towards "adult" stem cells -- which are closer to clinical applications, albeit ...
Stem Cell Research: The Future is Now
Stem Cell Research: The Future is Now B'nai B'rith International hosted a luncheon Nov.
First Use Of Antibody And Stem Cell Transplantation To Successfully Treat Advanced Leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
Gene Therapy Technique Slows Brain Disease ALD Featured In Movie 'Lorenzo's Oil'
These findings appear in the 6 November 2009 issue of the journal Science , which is published by AAAS, the nonprofit science society.
Viewpoints: State puts stem cell research on fast track
One thing that has always set California apart is our drive to innovate. That spirit is part of our DNA.
Stem Cell Therapy International, Inc. and Histostem Korea Announce...
OTCBB : SCII ) and its soon to be subsidiary, Histostem Ltd. of South Korea , announced that they recently supplied hematopoietic stem cells to The Queen Mary Hospital of the University of Hong Kong, China, for treatment of Leukemia patients.
Scientists identify molecular disparity between iPS cells and embryonic stem cells
The same genes that are chemically altered during normal cell differentiation, as well as when normal cells become cancer cells, are also changed in stem cells that scientists derive from adult cells, according to new research from Johns Hopkins and Harvard.
Geron trial may resume next year
The Phase I trial, which received clearance from the US Food and Drug Administration in January to administer hESC-derived progenitors of neural support tissue into the spinal cords of patients with severe spinal cord injury, is the first-ever clinical trial of a hESC-based therapy.
Kevin Perrott, reflected against the sky, has started a foundation to help dispel the myths about stem-cell research.
Revealing The Possible Origins Of Pancreatic Cancer
Main Category: Pancreatic Cancer Also Included In: Biology / Biochemistry ; Stem Cell Research Article Date: 03 Nov 2009 - 3:00 PST Study results: MIT cancer biologists have identified a subpopulation of cells that can give rise to pancreatic cancer .
NOXXON Announces Initiation of First-in-Human Clinical Trial with...
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of ...
Immune Therapy Can Protect Against Or Treat Later Lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection, said a group of researchers led by those from Baylor College of Medicine, The Methodist Hospital and Texas Childrena s ...
Stanford, Gladstone get $10M for cardiac stem cell consortium
Scientists with the Gladstone Institute of Cardiovascular Disease and Stanford University School of Medicine will use $10 million in federal funding over the next seven years to see how induced pluripotent stem cells can repair damaged heart muscle.
Drugs policy must be based on evidence
Ministers can't expect to get the best advice if scientists know they can be sacked for telling the scientific truth as they see it Did David Nutt overstep the line in his role as independent science adviser? Does there need to be a line at all? My answers are, no and yes, respectively.
Geron and FDA Reach Agreement on Clinical Hold
The plan is expected to enable Geron to re-initiate the Phase I clinical trial of GRNOPC1 in patients with complete thoracic spinal cord injury and to support future expansion of the trial to patients with cervical injuries.
Catholic Diocese To Oppose Embryonic Stem Cell Vote
Sioux Falls Catholic Diocese today asked it's 128-thousand parishoners to not support a movement to bring legalizing "embryonic stem cell research" to a public vote next year.
Immunotherapy demonstrates long-term success in treating lymphoma
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue.
Also on Topix